ArticleCancer biology & therapy2020

Co-targeting p53-R249S and CDK4 synergistically suppresses survival of hepatocellular carcinoma cells.

Huai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.